8,517 articles
James W. Putney
James W. Putney is an American pharmacologist at the National Institute of Environmental Health Sciences known for proposing capacitative calcium entry, now called store-operated calcium entry.
James Walker Dawson
James Walker Dawson (1870–1927) was a Scottish pathologist at the Royal College of Physicians' Laboratory in Edinburgh whose landmark 1916 monograph on multiple sclerosis gave medicine the Dawson's fingers MRI sign.
Jamie L. Renbarger
Jamie L. Renbarger is an American pediatric hematology-oncology physician-scientist who spent 21 years at Indiana University studying chemotherapy toxicities in children, winning a PECASE award in 2011.
Jamy D. Ard
Jamy D. Ard is an American physician-scientist in obesity medicine and clinical nutrition, vice dean at Wake Forest University School of Medicine and co-director of its Weight Management Center.
Jan A. Burger
Jan A. Burger is a German-trained hematologist and professor at MD Anderson Cancer Center who studies chronic lymphocytic leukemia and led the RESONATE-2 trial of ibrutinib.
Jan A. Staessen
Jan A. Staessen is a Belgian hypertension researcher, emeritus professor at the University of Leuven who led the Syst-Eur trial and pioneered home blood pressure measurement.
Jan B. Vermorken
Jan B. Vermorken is a Dutch medical oncologist who led medical oncology at the University of Antwerp and Antwerp University Hospital, known for the EXTREME and TAX 323 trials.
Jan C. Semenza
Jan C. Semenza is an environmental epidemiologist who led the CDC response to the 1995 Chicago heat wave and studied climate change and infectious disease at ECDC.
Jan Claassen
Jan Claassen is a German-trained neurologist and neurocritical care specialist who is Chief of Critical Care and Hospitalist Neurology at Columbia University, known for detecting hidden consciousness.
Jan Cools
Jan Cools is a Belgian leukemia genetics researcher and full professor at KU Leuven, known for identifying FIP1L1-PDGFRA as imatinib's target in hypereosinophilic syndrome and for the NUP214-ABL1 oncogene in T-ALL.
Jan D. Blankensteijn
Jan D. Blankensteijn, born 1959 in Aruba, is a Dutch vascular surgeon and full professor at Amsterdam UMC, known for leading the DREAM trial of abdominal aortic aneurysm repair.
Jan F. Heymans
Jan F. Heymans, also known as Jan Frans or Jean François Heymans, was a Belgian pharmacologist who held Belgium's first chair of experimental pharmacology at Ghent University.
Jan G. Waldenström
Jan Gösta Waldenström (1906–1996) was a Swedish physician and medical researcher, professor of internal medicine at Lund University, who first described Waldenström macroglobulinemia and classified gammopathies as monoclonal or polyclonal.
Jan Grimm
Jan Grimm is a German-trained physician-scientist in radiology and nuclear medicine who leads a molecular imaging laboratory at Memorial Sloan Kettering Cancer Center in New York.
Jan H.M. Schellens
Jan H.M. Schellens, born Johannes Henricus Matthias Schellens in 1956, is a Dutch medical oncologist at the Netherlands Cancer Institute and Utrecht University known for DPYD genotype-guided dosing of fluoropyrimidine chemotherapy.
Jan Jesenius
Jan Jesenius, also known as Ján Jesenský, was a Central European physician, surgeon, anatomist and politician best known for performing Prague's first public autopsy in 1600.
Jan Koch‐Weser
Jan Koch-Weser is a physician and clinical pharmacologist who led the Clinical Pharmacology Unit at Massachusetts General Hospital and later headed clinical research at Hoffmann-La Roche in Basel.
Jan Korbel
Jan O. Korbel is a geneticist and group leader at EMBL Heidelberg, where he has led research on genomic structural variation and cancer since 2008 and co-discovered chromothripsis.
Jan L. Breslow
Jan L. Breslow is an American physician-scientist at The Rockefeller University whose laboratory cloned apolipoprotein genes and created the first mutant mouse model of atherosclerosis.
Jan Nedergaard
Jan Nedergaard (J. Nedergaard) is a professor emeritus at Stockholm University's Wenner-Gren Institute, known for research on brown adipose tissue, nonshivering thermogenesis, and UCP1, and a member of the Royal Swedish Academy of Sciences.
Jan P. Vandenbroucke
Jan P. Vandenbroucke (J. P. Vandenbroucke) is a Belgian-born Dutch clinical epidemiologist, professor at Leiden from 1986 to 2015, coauthor of the STROBE reporting guidelines, and researcher of thrombosis risk from oral contraceptives.
Jan Struś
Jan Struś (Józef Struś, Latinized Josephus Struthius, 1510–1568) was a Polish Renaissance physician and burgomaster of Poznań whose book Sphygmicae artis transformed the study of the pulse.
Jan Tack
Jan Tack is a Belgian physician-scientist in gastroenterology, professor at KU Leuven and President of the Rome Foundation, known for research on functional dyspepsia and disorders of gut-brain interaction.
Jan van Bemmel
Jan van Bemmel, born 1938, is a Dutch medical informatics researcher who held the Netherlands' first university chair in the field, at the Free University Amsterdam.
Jan W. ten Cate
Jan W. ten Cate (Jan Wouter ten Cate, 1939–2020) was a Dutch internist and hematologist at the University of Amsterdam whose work fixed how deep-vein thrombosis is diagnosed and treated.
Jan Winberg
Jan Winberg was a Swedish professor of pediatrics at Karolinska Institutet, chair there from 1974 to 1989, known for influential research on urinary tract infections in children.
Jan‐Erik Johansson
Jan-Erik Johansson is a Swedish professor of urology and oncology at Örebro University and Örebro University Hospital, principal investigator of the SPCG-4 trial comparing prostate surgery with watchful waiting.
Jan‐Inge Henter
Jan-Inge Henter (born 1953) is a Swedish pediatric hematologist-oncologist and professor at Karolinska Institutet in Stockholm, known for defining hemophagocytic lymphohistiocytosis (HLH) and leading the international HLH-94 and HLH-2004 treatment studies.
Jane C. Davies
Jane C. Davies is a British physician-scientist and professor at Imperial College London who led the clinical trials bringing CFTR modulator drugs to people with cystic fibrosis.
Jane C. Weeks
Jane C. Weeks, also known as Jane Weeks, was an American oncologist at Dana-Farber Cancer Institute who pioneered cancer outcomes research before her death in 2013.